Matches in Nanopublications for { ?s ?p "[Incorporation of panels of prostate cancer risk SNPs into clinical practice offers potential to provide improvements in patient selection for prostate cancer screening; PSA interpretation (e.g. by correcting for the presence of SNPs that influence PSA expression levels; decision for biopsy (using prostate cancer risk SNPs); and possibly the decision for treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP1238308.RAE1iWWImWrewv4ZyE3QdfOh3VbuEflc2gtPvhjs-qGWc130_assertion description "[Incorporation of panels of prostate cancer risk SNPs into clinical practice offers potential to provide improvements in patient selection for prostate cancer screening; PSA interpretation (e.g. by correcting for the presence of SNPs that influence PSA expression levels; decision for biopsy (using prostate cancer risk SNPs); and possibly the decision for treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238308.RAE1iWWImWrewv4ZyE3QdfOh3VbuEflc2gtPvhjs-qGWc130_provenance.
- NP1238307.RA8Z12hyTqcsw5Y4vmlLRM_Nwu_fc5vp6N4gvhIkE3ZXM130_assertion description "[Incorporation of panels of prostate cancer risk SNPs into clinical practice offers potential to provide improvements in patient selection for prostate cancer screening; PSA interpretation (e.g. by correcting for the presence of SNPs that influence PSA expression levels; decision for biopsy (using prostate cancer risk SNPs); and possibly the decision for treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238307.RA8Z12hyTqcsw5Y4vmlLRM_Nwu_fc5vp6N4gvhIkE3ZXM130_provenance.